jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 29, 2021

Feb. 05, 2022

jRCT2032210400

Examination of the safety and the efficacy for patients using NP037 with chronic pain

Examination of the safety and the efficacy for patients using NP037 with chronic pain

Kondo Masako

Nipro Corporation

3023, Nojicho, Kusatsu, Shiga, JAPAN

+81-77-564-0500

kondo-masako@nipro.co.jp

Kondo Masako

Nipro Corporation

3023, Nojicho, Kusatsu, Shiga, JAPAN

+81-77-564-0500

kondo-masako@nipro.co.jp

Complete

Nov. 01, 2021

Nov. 08, 2021
50

Interventional

non-randomized controlled trial

open(masking not used)

uncontrolled control

single assignment

treatment purpose

Patients aged >=20 years at the time of consent, etc.

Patients whom an investigator or a sub-investigator judged to have difficulty in trial enforcement, etc.

20age old over
No limit

Both

Chronic pain

Put on a probe of NP037 in the pain site and treatment.

Changes in VAS from first use to the end of the first use

Nipro Corporation
Review Board of Human Rights and Ethics for Clinical Studies Institutional Review Board
2-2-1, Kyobashi, Chuo-ku, Tokyo

+81-3-5123-0028

soudan@hurecs.org
Approval

Oct. 29, 2021

No

none

History of Changes

No Publication date
3 Feb. 05, 2022 (this page) Changes
2 Dec. 01, 2021 Detail Changes
1 Oct. 29, 2021 Detail